Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 5:7:201.
doi: 10.3389/fonc.2017.00201. eCollection 2017.

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer

Stephen G Chun  1 , Timothy D Solberg  2 , David R Grosshans  1 , Quynh-Nhu Nguyen  1 , Charles B Simone 2nd  3 , Radhe Mohan  1 , Zhongxing Liao  1 , Stephen M Hahn  1 , Joseph M Herman  1 , Steven J Frank  1
Affiliations

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer

Stephen G Chun et al. Front Oncol. .
No abstract available

Keywords: carbon; heavy ion; hypofractionation; immune therapy; locally-advanced lung cancer.

PubMed Disclaimer

References

    1. Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol (2015) 16(2):187–99.10.1016/S1470-2045(14)71207-0 - DOI - PMC - PubMed
    1. Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, et al. Quality of life analysis of a radiation dose-escalation study of patients with non-small-cell lung cancer: a secondary analysis of the radiation therapy oncology group 0617 randomized clinical trial. JAMA Oncol (2016) 2(3):359–67.10.1001/jamaoncol.2015.3969 - DOI - PMC - PubMed
    1. Guberina M, Eberhardt W, Stuschke M, Gauler T, Heinzelmann F, Cheufou D, et al. Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial. Ann Oncol (2017) 28(5):1084–9.10.1093/annonc/mdx069 - DOI - PubMed
    1. Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, et al. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol (2017) 35(13):1387–94.10.1200/JCO.2016.70.0229 - DOI - PMC - PubMed
    1. Dess RT, Sun Y, Matuszak MM, Sun G, Soni PD, Bazzi L, et al. Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer. J Clin Oncol (2017) 35(13):1395–402.10.1200/JCO.2016.71.6142 - DOI - PMC - PubMed

LinkOut - more resources